1 September 2024

The Daily Mail: First condom designed to kill HIV "could be available to buy within months"

In an article that goes into a significant amount of scientific detail for a mainstream news publication, the Daily Mail covered the TGA of VivaGel coated condoms announcement. In addition, the social impact of the clinical milestone in the context of rising STI prevalence in Australia is discussed. It is reported that this remains “at a 20-year high”.

The Daily Mail forecasts that TGA approval will “pave the way for mass production”. The Daily Mail has an estimated adult readership of 4.2 million. At the time of publication, this article had received nearly 10,000 shares on social media. 


This contains certain forward-looking statements.

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.